Agenda

Friday, September 13, 2024

7:00 AM - 7:50 AM Registration and Breakfast/Coffee Talk with Key Opinion Leaders

In-person learners are invited to start off the morning with Key Opinion Leaders as well as other colleagues to enjoy coffee and informal discussions about a hot topic related to mood disorders.

8:00 AM - 8:10 AM Opening Remarks by Moderator Alan F. Schatzberg, MD

8:10 AM - 9:10 AM Keynote Session: Understanding AI in Mental Health and its Impact on Mood Disorders – Presented by JD Schramm, Ed.D. and John Torous, MD

ChatGPT is the most downloaded app in history. How is technology changing mental health care? As clinicians, it is important to understand generative AI technology and how it may impact patients and the practice of medicine. This session aims to build this understanding by focusing on GPT-4 and its potential impact on mental health care delivery. We first introduce key concepts and terminology describing how the technology works and various novel uses of it. We then hear how the availability of AI may have affected lived experience, and considerations for the role that AI and technology may play for those in crisis. We will dive into key considerations for GPT-4 and other large language models (LLMs) and wrap up with suggested future directions and initial guidance to the field. Using the APA app evolution framework, we will discuss issues related to equity, privacy, harm, efficacy, engagement, and clinical integration of LLMs with a special focus on clinical examples and practical implications for those working in different roles in the field. All recommendations will be in line with the APA’s 2023 statement on generative AI.

10-Minute Break

9:20 AM - 10:20 AM Non-CME Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company
The Patient Journey Through Bipolar II Depression Sponsored by Intra-Cellular Therapies, Inc. Presented by: Tracey Skale, MD

This program explores features of bipolar II depression that differentiate it from major depressive disorder. After exploring the patient journey, learn more about a treatment option approved for BOTH bipolar I and bipolar II depression in adults.

10-Minute Wellness Break

10:30 AM - 11:30 AM Tackling Tardive Dyskinesia in Older Patients With Mood Disorders – Presented by Robert Cotes, MD

In this interactive case-based session, we will explore the intersection of aging, mood disorders, and tardive dyskinesia. Expert faculty will delve into the complexities of tardive dyskinesia in patients with mood disorders in the long-term, and the importance of identifying and treating TD in patients with mood disorders as they age, and the safety of the medications available for treating TD.

11:30 AM - 12:30 PM Beyond the Surface: Exploring Inflammation as a Target for Mood Disorder Treatments – Presented by Jennifer Felger, PhD, MSc

A subset of patients with major depression exhibits elevated inflammation, associated with a characteristic symptomatology and reduced response to standard therapies. This session will explore relationships between inflammatory pathways and neuropathologies implicated in mood disorders, survey the predictive value of inflammatory markers for antidepressant resistance, and touch on potential novel targets for therapeutic intervention.

30-Minute Break & Lunch for in person attendees and book signing by JD Schramm, Ed.D.

1:00 PM - 2:00 PM Non-CME Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company
Beyond the Baseline: A Comprehensive Approach to Diagnosis and Treatment of Tardive Dyskinesia Sponsored by Neurocrine Biosciences, Inc. Presented by: Melissa A. Moody, MD

This program provides an overview of tardive dyskinesia, including its phenomenology, prevalence, risk factors, and impact. Faculty will share the clinical data for an FDA-approved treatment option for adults with tardive dyskinesia. In addition, participants will have the opportunity to examine cases of patients with tardive dyskinesia by observing videos of the patients before and after treatment. This non-CME educational program is sponsored by Neurocrine Biosciences.

10-Minute Wellness Break

2:10 PM - 3:10 PM From Diagnosis to Empowerment: Patient-Centered Strategies for Optimizing Management of Bipolar I Disorder – Presented by Leslie Citrome, MD, MPH

This session delves into the complexities of bipolar I disorder, focusing on achieving diagnostic accuracy, exploring new and emerging pharmacologic treatments, and emphasizing patient-centered maintenance treatment. Through a comprehensive review of clinical evidence and real-world case studies, this session aims to eqiup healthcare professionals with the tools to improve patient care for those with bipolar I disorder.

10-Minute Break

3:20 PM - 4:20 PM Non-CME Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company
Treating MDD: A Rapid-Acting Oral Antidepressant with Multimodal Activity Sponsored by Axsome Therapeutics, Inc. Presented by: Gregory Mattingly, MD

This branded symposium will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD. This non-CME educational program is sponsored by Axsome Therapeutics, Inc.

5-Minute Break

4:25 PM - 5:25 PM Do Novel Mechanisms for Depression Treatment Herald Brighter Days Ahead for Patients with Residual Anhedonia? – Presented by Lisa Harding, MD

Anhedonia is a prominent residual symptom in many patients with Major Depressive Disorder (MDD) that profoundly impacts their quality of life. This session will explore the significant burden that residual anhedonia imposes on patients and the healthcare system. Participants will delve into the underlying pathophysiology of anhedonia that current treatments fail to address, learn to detect anhedonia using specialized assessment tools, and examine novel mechanisms that target the neurobiological basis of this debilitating symptom.

5:25 PM - 5:30 PM Closing Remarks by Moderator Alan F. Schatzberg, MD

5:30 PM - 6:30 PM - Welcome Reception

In-person learners are invited to join us at the welcome reception on the Sonoran Terrace, Friday evening after the first day of the conference. Connect with familiar colleagues, network with new faces, and spark meaningful conversation over food, music, and fun in this atmosphere of intellectual curiosity!

Saturday, September 14, 2024

6:30 AM - 7:00 AM Registration and Breakfast

7:00 AM - 7:05 AM Opening Remarks by Moderator Alan F. Schatzberg, MD

7:05 AM - 8:05 AM A Person-Centered Approach to Crisis De-escalation in Patients with Mood Disorders – Presented by Samantha Rabins, LCSW

It's suicide awareness week and we are at a Mood Disorders Summit. Let's talk about a person-centered approach to de-escalation, honing our skillsets in recognizing triggers, implementing strategies to reduce tension and promote safety, determine when additional crisis intervention resources are needed, and construct safety plans for people who are in crisis.

5-Minute Break

8:10 AM - 9:10 AM Elevating MDD Care: Integration of Prescription Digital Therapeutics Into MDD Treatment – Presented by David Mohr, PhD

Digital therapeutics can leverage neuroplasticity to address residual symptoms in MDD. This session explores the evolving role of prescription digital mental health therapies in the treatment of MDD, providing practical strategies for prescribing, counseling patients, and integrating them into patient care plans.

10-Minute Break

9:20 AM - 10:20 AM Non-CME Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company
Long-Term Strategies in Treatment-Resistant Depression Sponsored by Johnson & Johnson. Presented by: Rayan Al Jurdi, MD and Karah Brashier, DNP, APRN, MSN, C-PMHNP

“Long-Term Strategies in Treatment-Resistant (TRD) Depression,” an educational program focusing on the continuing care of adult patients with TRD.
- Review a patient case study to define treatment-resistant depression (TRD)—patients with major depressive disorder (MDD) with an inadequate response to 2 or more oral antidepressants—and review some of their most important concerns
- Clinical efficacy data in TRD for SPRAVATO® (esketamine) CIII nasal spray
- 5+-year results from a long-term, open-label safety study of SPRAVATO^®
- Factors to consider when starting patients on SPRAVATO^®
- Important Safety Information

This non-CME educational program is sponsored by Johnson & Johnson.

10-Minute Wellness Break

10:30 AM - 11:30 AM Empowering Recovery: Targeted Therapies for Postpartum Depression – Presented by Jennifer Payne, MD

Novel targeted treatment options are now available for postpartum depression. The session will discuss screening and diagnostic strategies, the latest clinical evidence for new and emerging treatment options in PPD, and real-world patient cases.

11:30 AM - 12:30 PM Addressing the Complexities of Bipolar Depression with DSM Specifiers – Presented by Charles DeBattista, MD

Bipolar depression identification and management can be confusing in the presence of the DSM-V-TR specifiers, including mixed features and anxious distress. This session will seek to clarify best practices for identification and management of bipolar depression with DSM-V-TR specifiers, through interactive case-based discussions.

30-Minute Break & Lunch

1:00 PM - 2:00 PM Non-CME Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company
A Clinical Overview of VRAYLAR: Managing the Full Spectrum of Bipolar I Disorder in Adults Sponsored by AbbVie Pharmaceuticals. Presented by: Rakesh Jain, MD

This presentation provides a clinical overview of VRAYLAR (cariprazine), for the treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults and the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. This non-CME educational program is sponsored by AbbVie Pharmaceuticals.

10-Minute Wellness Break

2:10 PM - 3:10 PM Clinical Crossroads: Navigating MDD Treatment Challenges Through Real-World Cases – Presented by Greg W. Mattingly, MD

This interactive session will address the complexities of treating Major Depressive Disorder (MDD) through the use of real-world patient cases illustrating common and challenging scenarios in MDD management, focusing on adjunctive therapy strategies. Through these cases, evidence-based adjunctive therapies will be explored, discussing their practical application in clinical settings. This session aims to equip clinicians with the skills and knowledge to navigate the intricacies of MDD treatment, optimize patient outcomes, and personalize care plans.

3:10 PM - 4:10 PM Unlocking Hope: Psychedelics in the Treatment of Major Depressive Disorder – Presented by Joshua Woolley, MD, PhD

Research into the potential psychiatric utility of psychedelic drugs has been ongoing for decades but has only lately begun to reach mainstream clinical practice. This session will cover current clinical evidence for use of agents such as psyilocybin, MDMA, and ketamine for treatment of major depression, as well as providing resources for clinicians interested in offering psychedelic-assisted therapy for their patients.

4:10 PM - 4:15 PM Closing Remarks by Moderator Alan F. Schatzberg, MD

Location

Venue Name

JW Marriott Scottsdale Camelback Inn

Address

JW Marriott Scottsdale Camelback Inn
5402 East Lincoln Drive
Scottsdale, Arizona 85253

Room Name

Paradise Ballrooms

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in applying diagnostic considerations and assessing new and emerging therapies for the treatment of mood disorders.

Target Audience
This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with mood disorders.

Learning Objectives
Upon completion of this event, participants should be able to:

Discuss current events and hot topics in mood disorders.
Describe best practices for diagnosis and management of mood disorders.
Assess clinical evidence for new and emerging treatment options in mood disorders.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 11.0 contact hours. Pharmacology contact hours will be designated on your certificate.

Continuing Pharmacy Education

CCO designates this continuing education activity for 11.0 contact hours (1.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: UANs will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 11.0 continuing education credits for psychologists.

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 11.0 clinical continuing education credits.

ABMS Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Understanding AI in Mental Health and Its Impact on Mood Disorders; Tackling Tardive Dyskinesia in Older Patients With Mood Disorders; Do Novel Mechanisms for Depression Treatment Herald Brighter Days Ahead for Patients with Residual Anhedonia?; From Diagnosis to Empowerment: Patient-Centered Strategies for Optimizing Management of Bipolar I Disorder; Beyond the Surface: Exploring Inflammation as a Target for Mood Disorder Treatments; Addressing the Complexities of Bipolar Depression with DSM Specifiers; Empowering Recovery: Targeted Therapies for Postpartum Depression; Clinical Crossroads: Navigating MDD Treatment Challenges Through Real-World Cases; Unlocking Hope: Psychedelics in the Treatment of Major Depressive Disorder; A Person-Centered Approach to Crisis De-escalation in Patients with Mood Disorders has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options and in cooperation with American Foundation for Suicide Prevention

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; and Sage Therapeutics, Inc. and Biogen.

Clinical Education Alliance Terms and Conditions

These Terms of Use ("Terms") apply to your use of the websites, mobile applications and other resources provided by Clinical Education Alliance LLC (“CEA”) and its affiliates (referred to collectively as "CEA," "us," "we" and "our") that are intended for use by healthcare professionals, which we refer to as the "CEA Network," including the personalized information and services that meet the needs and interests of users of the CEA Network such as medical news, reference content, clinical tools, applications, sponsored programs, advertising, email communications, continuing medical education, market research opportunities and discussion forums (collectively, the "Services"). You will always be able to view the most current version of these Terms by clicking on the Terms of Use link at the bottom of any page of a CEA Network property. Note that these Terms do not apply to our properties and services that display a link to different terms of use. In the event that we expand the CEA Network through our acquisition of another company and/or its properties, that company may operate its properties subject to its own terms of use accessible via a link on such properties until we integrate its practices with ours, at which point a link to these Terms will be displayed on its properties. By using the Services, you agree to these Terms, whether or not you are a registered member of the CEA Network. These Terms govern your use of the Services and create a binding legal agreement that we may enforce against you in the event of a violation. If you do not agree to all of these Terms of Use, do not use the Services!

We reserve the right to change these terms from time to time. The most current version may be viewed by clicking on the “Terms of Use” link at the bottom of designated pages on the Clinical Education Alliance Sites. Use of the Clinical Education Alliance Sites after the effective date constitutes acceptance of the amended Terms of Use. When you leave a CEA Web site and go to another Web site, different terms apply and CEA has no responsibility or liability for any content on those sites.

Clinical Education Alliance Content

The Clinical Education Alliance Sites incorporate information, including modules, capsules, journal articles, medical news, references, interactive case studies, other continuing education material, downloadable software applications, advertising, and other healthcare information, which is intended for adults who are licensed healthcare professionals. This information is not intended to serve as a substitute for the healthcare professional’s clinical judgment. If you are a consumer who chooses to read this professional-level information on Clinical Education Alliance Sites, you should not use or rely on that information as professional medical advice or use it to replace any relationship with your physician or other qualified healthcare professional or any information they may have provided to you. For medical issues or concerns, including decisions about medications and other treatments, consumers should always consult their physician or, in serious cases, seek immediate assistance from emergency personnel.

The Content on the Clinical Education Alliance Sites is developed or selected in accordance with our published Editorial Policies. However, users access and use this material at their own risk. It is the reader’s job to evaluate the accuracy of any information and results from interactive programs found on the Clinical Education Alliance Site. If you are a healthcare professional, you should rely on your professional judgment in evaluating any and all information and confirm the information contained on the Clinical Education Alliance Sites with other sources and reliable third parties before basing any treatment or advice on it. If you are a consumer, you should evaluate the information together with your physician or another qualified healthcare professional.

DISCLAIMERS AND LIMITATIONS OF LIABILITY

THE CONTENT, APPLICATIONS, SOFTWARE, AND ALL OTHER MATERIAL ON THE CLINICAL EDUCATION ALLIANCE SITES ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. ALL WARRANTIES, EXPRESS OR IMPLIED, ARE HEREBY DISCLAIMED. CLINICAL EDUCATION ALLIANCE SHALL NOT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, PHYSICAL HARM OR INJURIES, LOST REVENUES, OR LOST PROFITS, RESULTING FROM THE USE OR MISUSE OF THE CLINICAL EDUCATION ALLIANCE SITES, OR ANY INFORMATION, APPLICATIONS, MATERIALS, OR SOFTWARE THEREON, EVEN IF CLINICAL EDUCATION ALLIANCE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, OR FOR ANY CLAIM BY ANOTHER PARTY. CLINICAL EDUCATION ALLIANCE DOES NOT WARRANT THAT THIS SITE OR ANY APPLICATIONS OR SOFTWARE WILL BE FREE OF BUGS, INACCURACIES, OR ERRORS, NOR DOES CLINICAL EDUCATION ALLIANCE WARRANT THAT ANY SITE, SOFTWARE, OR APPLICATION IS FREE OF VIRUSES OR OTHER HARMFUL ELEMENTS.

A user’s use of the Clinical Education Alliance Sites, and any reliance on any materials, information, software, or applications, is at the user’s own risk. You agree that you hereby release Clinical Education Alliance and its affiliates, owners, respective directors, officers, employees, advertisers, authors, and contributors from any and all liability or obligations arising from the use of the Clinical Education Alliance Sites. A user’s sole remedy for any problem or concern is to exit the Web site or application. You agree that you will indemnify and hold Clinical Education Alliance harmless for any loss, damages, or liability suffered by Clinical Education Alliance as a result of your use of any Clinical Education Alliance Site or material, application, information, or software thereon or your submission of any material to Clinical Education Alliance. Clinical Education Alliance reserves the right to restrict or limit access to this Web site.

CEA Programs, Tools, and Databases

The Clinical Education Alliance Sites include interactive programs, clinical tools, and databases intended for the use of healthcare professionals. These materials are not intended as professional advice or recommendations of particular products. Physicians and other healthcare professionals who use our interactive programs, tools, or databases should exercise their own clinical judgment as to the results. Consumers who use the tools or databases do so at their own risk.

Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. For medical concerns or issues, including decisions about medications and other treatments, users should always consult their physician or other qualified healthcare professional.

Ownership of Clinical Education Alliance Sites—Copyright and Trademarks

The entire contents and design of the Clinical Education Alliance Sites, including the software applications, tools, and databases, are protected under US and international copyright laws. These materials are owned by CEA or its affiliates or are used with permission of their owners or as otherwise authorized by law. All rights are reserved, worldwide. You may look at the Clinical Education Alliance Sites, download individual articles or applications to your personal computer or handheld device, and print a reasonable number of pages for your own personal reference. You must not remove any copyright notices from our materials. We reserve all our other rights. This means you may not sell, rewrite, or modify any content or other material found on any Clinical Education Alliance Site, redistribute it, put it on your own Web site, or use it for any commercial purpose without our prior written authorization.

The names of the CEA products and services are protected by trademark laws in the United States. Any use of our trademarks or service marks requires prior written approval from CEA.

You may link to a CEA Web site if your Web site offers products, services, or information of interest to the professional healthcare community. You are not allowed to link to the Clinical Education Alliance Sites if you post illegal, obscene, or offensive content or if the link is likely to have a negative impact on CEA’s reputation. Any other use, such as framing any part of a CEA Web site or incorporating any CEA content into another Web site, product, or application, requires advance written permission from Clinical Education Alliance. Clinical Education Alliance assumes no responsibility for any Web sites or materials that are linked to Clinical Education Alliance Sites or materials.

Software Products and Applications

Clinical Education Alliance makes some software and accompanying documentation available for downloading from our Web sites and/or from iTunes. These materials are protected by copyrights under US and international law and are owned by Clinical Education Alliance or companies that have licensed the software to us. We do not transfer any ownership rights in software or documentation to you when you download it from our Web site and/or directly from iTunes. You may use the software and accompanying documentation for their intended purpose. You are not authorized to further copy or distribute the software and accompanying documentation, nor may you attempt to recreate or reverse engineer our software or applications. In addition, some software available for downloading from our Web sites and/or from iTunes is subject to US export controls. By downloading or using such software, you are representing to us that your download of such software complies with these controls.

US Government End Users

If you are affiliated with the US government, please note that the software and documentation available on our Web sites and/or directly from iTunes are “commercial items,” as that term is defined in 48 C.F.R. 2.101 (October 1995), consisting of “commercial computer software” and “commercial computer software documentation,” as such terms are used in 48 C.F.R. 12.212 (September 1995). Consistent with 48 C.F.R. 12.212 and 48 C.F.R. 227.7202-1 through 227.7202-4 (June 1995), all US government end users acquire the software and documentation with only those rights set forth herein.

Social Media, Message Boards, and Forums

Clinical Education Alliance offers users the opportunity to engage in social media interactions with both experts and other users of the sites. As with other online social media, users must exercise sound judgment in both the information that they post and in how they assess the postings of other users. As such, users are expected to adhere to the social media recommendations made by the American Medical Association when utilizing the social media capabilities of CEA sites. In particular, users must be cognizant of standards of patient privacy and confidentiality that must be maintained in all environments and must not post identifiable patient information on CEA sites. In social media interactions, users must maintain appropriate boundaries of the patient–physician/care provider relationship in accordance with professional ethical guidelines just as they would in any other context. Users acknowledge that privacy settings are not absolute and that once on the Internet, content posted by them may be copied by third parties and republished out of the control of Clinical Education Alliance. Thus, users should routinely monitor their own Internet presence to ensure that the personal information and content that they post and, to the extent possible, that is posted about them by others is accurate and appropriate.

Users are expected to refrain from submitting comments or messages that are defamatory, hateful, or obscene or that harass others. Users may not impersonate any other person or violate any other person’s or entity’s legal rights or submit falsified credentials or experiences. Users agree that they will not submit any materials that violate or infringe any copyrights, trademarks, patents, trade secret, or other intellectual property rights of any third party. Clinical Education Alliance retains all copyrights in the content posted by users to its sites. Clinical Education Alliance may adopt additional rules to govern use of social media, message boards or forums, to which users will be subject.

Copyright and Other Legal Violations

If you believe that any material on this Web site infringes your copyright, please notify us as follows, under the Digital Millennium Copyright Act (“DMCA”). To notify us, the DMCA requires that you: 1. Send an email notice to Clinical Education Alliance at customersupport@clinicaloptions.com. 2. Include the following information in your email: a. Identify the copyrighted work(s) you claim is infringed; b. Identify the material you claim is infringing the copyright(s) and give enough information for Clinical Education Alliance to locate that material; c. Include a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf (the “Claimant”); d. Include the Claimant’s name, address, and telephone number(s); e. Include a statement that the Claimant has a good faith belief that use of the disputed material is not authorized by the copyright owner or his agent; and f. Include a statement, under penalty of perjury, that the information in the notification of copyright infringement is accurate and that the Claimant is the copyright owner or is authorized to act on behalf of the copyright owner.

If you believe any content or material on the Clinical Education Alliance Sites violates any laws, please notify customersupport@clinicaloptions.com. Please include details about your concerns and an email address for contacting you.

Governing Law

Clinical Education Alliance controls the Clinical Education Alliance Sites from its offices in the state of Virginia in the United States of America. The Clinical Education Alliance Sites can be accessed from any of the United States and from other countries worldwide. Since the laws of each state or country may differ, both you and Clinical Education Alliance agree that the laws of Virginia, without regard to conflicts of laws principles, will apply to all matters relating to use of the Clinical Education Alliance Sites and materials, including software and applications.

Clinical Education Alliance makes no representation that materials on these sites are appropriate or available for use in countries aside from the United States. Accessing the Clinical Education Alliance Sites from territories where their contents are illegal is prohibited. Those who choose to access these sites from other locations do so at their own risk and are responsible for compliance with any and all applicable local laws or regulations.

Acceptance Procedure

By downloading or accessing materials on the Clinical Education Alliance Sites and/or directly from iTunes or registering with us, you agree to all the terms and conditions in this agreement, including the Terms of Use and Privacy Policy. If you disagree with any of these Terms of Use or Privacy Policy, please refrain from using the Clinical Education Alliance Sites or materials.

Privacy Policy

Because we provide education for healthcare professionals, we pay special attention to privacy issues. The purpose of our Privacy Policy is to identify the information we may collect about you, describe the uses we may make of your information and the security measures we take to protect it, and discuss your options for controlling your information. You can review our Privacy Policy by clicking on the “Privacy Policy” link at the bottom of designated pages on the Clinical Education Alliance Sites.

Disputes

If you fail to comply with these terms, we have the right to suspend or eliminate your account and remove any information you have placed on our site, including your registration information. We may also take any legal action we think is appropriate. If there is any dispute between us concerning this agreement or your use of any Clinical Education Alliance Site or materials or applications, we both agree to submit the dispute to nonbinding mediation, followed by binding arbitration. Both the mediation and the arbitration will be governed under the rules of the American Arbitration Association, and the venue for the arbitration will be Virginia.

Questions or Concerns About Our Terms of Use

For questions or concerns about these Terms of Use, please send an email to customersupport@clinicaloptions.com

These terms of use were last updated in July 2021.

11th Annual Mood Disorders Summit 2024

Who Should Attend

Time and location

Faculty

Rayan Al Jurdi, MD

Karah Brashier, DNP, APRN, MSN, C-PMHNP

Leslie Citrome, MD, MPH

Robert O. Cotes, MD, DFAPA

Charles DeBattista, DMH, MD

Jennifer C Felger, PhD, MSc

Lisa Harding, MD

Rakesh Jain, MD

Greg W Mattingly, MD

David C Mohr, PhD

Melissa A Moody, MD

Jennifer L. Payne, MD

Alan F. Schatzberg, MD

JD Schramm, EdD

Tracey Skale, MD

John Torous, MD

Joshua Woolley, MD, PhD

Agenda

Location

Venue Name

Address

Room Name

CME/CE Info

Accreditation

Acknowledgement

Contact Information

Additional Information